
Advocating for Awareness: Enhancing Sepsis Recognition and Response in Home Infusion Care - INFUSION Article
-
Register
- Prices available after logging in
Home infusion clinicians need to effectively address sepsis in patients through early recognition, prompt intervention, and a collaborative approach. This article provides information on standardized assessment tools, common home infusion-related infections, and interdisciplinary involvement in patient monitoring and communication among providers.
Learning Objectives:
- Describe sepsis and its clinical manifestations in the home infusion setting.
- Identify key risk factors of sepsis in home infusion patients to facilitate early recognition and intervention.
- Discuss monitoring strategies for home infusion therapy patients to prevent and manage infections.
- Determine the most common home infusion-related infections and their prevention strategies.

Anthony Casapao, PharmD, MPH, BCIDP, FIDSA
Clinical Associate Professor
University of Florida College of Pharmacy
He earned his Doctor of Pharmacy degree from Wingate University. He then completed postgraduate pharmacy practice and infectious diseases residency training at St. Vincent’s Medical Center and the University of Pittsburgh Medical Center, respectively. He continued his love of infectious diseases by completing a fellowship in health economics and outcomes research at Wayne State University. He further developed his research skills by completing a master's degree in public health with a concentration in Epidemiology and Biostatistics at Harvard University.
His research focuses on pharmacoepidemiology, evaluating post-marketing data, and applying more extensive data to understand public health problems and explore possible solutions. He also focuses on the off-label use of antimicrobials with comparative effectiveness methodologies, expanding on previous subject knowledge, applying more robust data, and providing confirmatory conclusions for controversial data. His substantial research focuses on antimicrobial resistance and the clinical implications of anti-infective therapies from a One Health perspective.
Dr. Casapao has published extensively in peer-reviewed journals and is a Fellow of the Infectious Diseases Society of America. At the University of Florida, he teaches, mentors, and guides students through their professional development, particularly in infectious diseases.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Anthony Casapao has no relevant financial relationships with ineligible companies to disclose.
Tiffany Hart, BS
PharmD Candidate
University of Florida College of Pharmacy
Tiffany Hart is a PharmD candidate at the University of Florida College of Pharmacy, expected to graduate in May of 2025. She previously earned a Bachelor of Science in Psychology with a focus on counseling psychology from the University of Florida. Tiffany has a particular interest in pediatrics, neonatology, infectious disease, and psychiatric pharmacy, and is passionate about advancing care in these specialties through clinical practice and research. Tiffany is currently pursuing a residency program with the goal of becoming a clinical pediatric pharmacist, where she hopes to integrate her interests in pediatric care and infectious disease to improve patient outcomes.
In addition to her academic achievements, Tiffany is an active student leader at the University of Florida. She co-founded the Asian Student Pharmacist Coalition (ASPC) in 2022 and served as President for two terms, fostering community and advocating for diversity within the pharmacy program. Tiffany is also a dedicated Student Ambassador and Pharmacy Early Acceptance Program Mentor, roles through which she champions student advocacy and enhances representation of the profession. Although this is Tiffany's first publication, she is excited to continue contributing to medical writing and research throughout her career.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Tiffany Hart has no relevant financial relationships with ineligible companies to disclose.

Olga Afanaseva, MS
PharmD Candidate
University of Florida College of Pharmacy
I am a second-year PharmD student at the University of Florida College of Pharmacy. I was born in Russia and relocated to the United States with my family in 2018. I am passionate about clinical pharmacy and infectious diseases, with a strong interest in pharmacotherapy and patient care.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Olga Afanaseva has no relevant financial relationships with ineligible companies to disclose.

Timber Abinsay, AA
PharmD Candidate
University of Florida College of Pharmacy
Timber Abinsay is currently a second year pharmacy student at the University of Florida College of Pharmacy at the Jacksonville Campus and is expected to graduate in May 2027. She plans on doing a residency after graduation and her current areas of interest are Emergency Medicine, Critical Care, and Ambulatory Care. She hopes to make a difference in the lives of her patients and to advocate for her patients care which is her main motivation for being a pharmacist.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Timber Abinsay has no relevant financial relationships with ineligible companies to disclose.
Key:




